Skip to main content

Find Clinical Trials

Home
Conditions
Cytopenias

Clinical trial condition

Cytopenias

Explore clinical trials studying Cytopenias. Study availability and eligibility vary by location and protocol.

16 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Cytopenias trial results

Completed

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

NCT00002009

Conditions: Blood-Borne Infections, Communicable Diseases, Cytopenia, +17 more
Locations: UCLA CARE Ctr Los Angeles, California, United States

Beth Israel Deaconess - West Campus Boston, Massachusetts, United States

View Trial Details

Completed

The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic

NCT00002303

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Anemia, +19 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia

NCT00002258

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood Platelet Disorders, +22 more
Locations: New England Deaconess Hosp Boston, Massachusetts, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

NCT00002071

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia

NCT00002007

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +19 more
Locations: Natl Cancer Institute Bethesda, Maryland, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

NCT00002073

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details